CATEGORY: CLINICAL

Real-World Evidence (RWE)

Clinical evidence derived from real-world data (registries, EHRs, claims data) rather than randomized controlled trials. FDA and EU MDR increasingly accept RWE for post-market studies, label expansions, and certain premarket submissions.

Last reviewed 2026-08-05 · Reviewed by MedFlux Editorial Board · Editorial policy

WHEN IT APPLIES

Real-world evidence (RWE) is clinical evidence derived from real-world data (RWD) such as registries, EHRs, and claims—increasingly used to support regulatory decisions and PMCF.

PROCESS / STEPS

Define regulatory question and fitness-for-purpose of RWD sources.
Address bias, confounding, and data quality.
Analyze and report transparently for submissions or CER/PMCF.
Combine with traditional trials when needed.

EXAMPLES

Postmarket label expansions sometimes leverage RWE packages when RCTs are impractical.

RELATED GUIDES & TOOLS

SOURCES

FDA RWE program ↗

Track regulatory signals related to Real-World Evidence (RWE) across 27 authorities in real time.

START FREE →